Indoco Remedies Limited — Important, 17-12-2024: General Updates

The USFDA has issued a warning letter to Indoco Remedies Limited's Plant II & Plant III facilities in Goa, following an inspection conducted from July 16 to July 26, 2024, which resulted in an Official Action Indicated (OAI) status notified in October 2024. The company acknowledges the importance of compliance and is committed to promptly addressing the issues highlighted by the USFDA. Despite this setback, Indoco continues to supply products from these facilities to fulfill its commitments to customers and patients in the United States. Investors should monitor this situation closely, as compliance challenges may affect operational efficiencies and regulatory standing.